Lint: amorphous-calcification-within-breast

"Given the 20% positive predictive value of malignancy, most amorphous calcifications are assessed as BI-RADS 4B (suspicious, warranting biopsy) ⁵. That assessment particularly applies to amorphous calcifications with a grouped, linear, or segmental distribution. However, bilateral diffuse amorphous calcifications may be assessed as BI-RADS 2 (benign). If long-term (2-3 year) stability has been demonstrated, a BI-RADS 2 assessment would also be appropriate."

"Given the 20% positive predictive value of malignancy, most amorphous calcifications are assessed as BI-RADS 4B (suspicious, warranting biopsy) ⁵. That assessment particularly applies to amorphous calcifications with a grouped, linear, or segmental distribution. However, bilateral diffuse amorphous calcifications may be assessed as BI-RADS 2 (benign). If long-term (2-3 year) stability has been demonstrated, a BI-RADS 2 assessment would also be appropriate."

"Given the 20% positive predictive value of malignancy, most amorphous calcifications are assessed as BI-RADS 4B (suspicious, warranting biopsy) ⁵. That assessment particularly applies to amorphous calcifications with a grouped, linear, or segmental distribution. However, bilateral diffuse amorphous calcifications may be assessed as BI-RADS 2 (benign). If long-term (2-3 year) stability has been demonstrated, a BI-RADS 2 assessment would also be appropriate."

"If the interpreting radiologist has sufficient personal experience with this finding to suggest"